Cofoe Medical Stock Soars 9.57%, Hits Intraday High of CNY 48.90

Cofoe Medical Technology Co., Ltd. has experienced a significant surge in its stock performance, gaining 9.57% on June 29, 2026. The stock reached an intraday high of CNY 48.90, reflecting strong market activity. Over the past year, Cofoe has outperformed the China Shanghai Composite, generating a return of 32.82% compared to the index's 16.78%. The company's financial metrics indicate robust growth, with net sales increasing by 37.22% and operating cash flow reaching a record CNY 729.3 million. Cofoe has reported positive results for three consecutive quarters, showcasing its strong operational performance. The return on equity stands at 7.26%, and the company maintains an attractive price-to-book ratio of 1.85. In terms of market positioning, Cofoe Medical Technology operates within the Pharmaceuticals & Biotechnology sector, with a market capitalization of CNY 8,774 million. The stock's performance over various time frames highlights its resilience, including a 6.29% increase over the past week and a 1.13% rise over the past month. Overall, Cofoe Medical Technology continues to demonstrate strong financial health and market performance.